TABLE 3

Ratio (after/before) of CPT1B, ACAB, and PPARD mRNA content in skeletal muscle in response to placebo, GW590735, and GW501516 treatment

TranscriptPlaceboGW590735GW501516ANOVA
n666
CPT1B0.85 ± 0.080.92 ± 0.071.19 ± 0.070.03
ACAB1.21 ± 0.091.09 ± 0.251.18 ± 0.140.71
PPARD1.11 ± 0.191.12 ± 0.250.95 ± 0.170.85
  • Data are means ± SE. Level of significance was calculated using ANOVA.